Mesterman R - Search Results

1

Mutations of AKT3 are associated with a wide spectrum of developmental disorders including extreme megalencephaly.

Alcantara D, Timms AE, Gripp K, Baker L, Park K, Collins S, Cheng C, Stewart F, Mehta SG, Saggar A, Sztriha L, Zombor M, Caluseriu O, Mesterman R, Van Allen MI, Jacquinet A, Ygberg S, Bernstein JA, Wenger AM, Guturu H, Bejerano G, Gomez-Ospina N, Lehman A, Alfei E, Pantaleoni C, Conti V, Guerrini R, Moog U, Graham JM Jr, Hevner R, Dobyns WB, O'Driscoll M, Mirzaa GM. Alcantara D, et al. Among authors: mesterman r. Brain. 2017 Oct 1;140(10):2610-2622. doi: 10.1093/brain/awx203. Brain. 2017. PMID: 28969385 Free PMC article.

2

Leigh syndrome associated with mitochondrial complex I deficiency due to novel mutations In NDUFV1 and NDUFS2.

Marin SE, Mesterman R, Robinson B, Rodenburg RJ, Smeitink J, Tarnopolsky MA. Marin SE, et al. Among authors: mesterman r. Gene. 2013 Mar 1;516(1):162-7. doi: 10.1016/j.gene.2012.12.024. Epub 2012 Dec 22. Gene. 2013. PMID: 23266820

3

Resting State and Diffusion Neuroimaging Predictors of Clinical Improvements Following Constraint-Induced Movement Therapy in Children With Hemiplegic Cerebral Palsy.

Manning KY, Fehlings D, Mesterman R, Gorter JW, Switzer L, Campbell C, Menon RS. Manning KY, et al. Among authors: mesterman r. J Child Neurol. 2015 Oct;30(11):1507-14. doi: 10.1177/0883073815572686. Epub 2015 Mar 11. J Child Neurol. 2015. PMID: 25762587

4

Neuroplastic Sensorimotor Resting State Network Reorganization in Children With Hemiplegic Cerebral Palsy Treated With Constraint-Induced Movement Therapy.

Manning KY, Menon RS, Gorter JW, Mesterman R, Campbell C, Switzer L, Fehlings D. Manning KY, et al. Among authors: mesterman r. J Child Neurol. 2016 Feb;31(2):220-6. doi: 10.1177/0883073815588995. Epub 2015 Jun 15. J Child Neurol. 2016. PMID: 26078420

5

Effects of Botulinum Toxin Treatment in Nonambulatory Children and Adolescents With Cerebral Palsy: Understanding Parents' Perspectives.

Nguyen L, Di Rezze B, Mesterman R, Rosenbaum P, Gorter JW. Nguyen L, et al. Among authors: mesterman r. J Child Neurol. 2018 Oct;33(11):724-733. doi: 10.1177/0883073818786567. Epub 2018 Jul 24. J Child Neurol. 2018. PMID: 30039731

6

A Long-term, epidemiological survey of outcome and adjustment of children with developmental disabilities.

Leitner Y, Yifat R, Mesterman R, Gilutz G, Levi-Hakeini O, Bitchonsky O, Harel S. Leitner Y, et al. Among authors: mesterman r. J Child Neurol. 2007 Feb;22(2):143-50. doi: 10.1177/0883073807300297. J Child Neurol. 2007. PMID: 17621474

7

Missense variants in the N-terminal domain of the A isoform of FHF2/FGF13 cause an X-linked developmental and epileptic encephalopathy.

Fry AE, Marra C, Derrick AV, Pickrell WO, Higgins AT, Te Water Naude J, McClatchey MA, Davies SJ, Metcalfe KA, Tan HJ, Mohanraj R, Avula S, Williams D, Brady LI, Mesterman R, Tarnopolsky MA, Zhang Y, Yang Y, Wang X; Genomics England Research Consortium; Rees MI, Goldfarb M, Chung SK. Fry AE, et al. Among authors: mesterman r. Am J Hum Genet. 2021 Jan 7;108(1):176-185. doi: 10.1016/j.ajhg.2020.10.017. Epub 2020 Nov 26. Am J Hum Genet. 2021. PMID: 33245860 Free PMC article.

8

Botulinum toxin-A use in paediatric hypertonia: Canadian practice patterns.

Fehlings D, Narayanan U, Andersen J, Beauchamp R, Gorter JW, Kawamura A, Kiefer G, Mason M, McCormick A, Mesterman R, Switzer L, Watt J. Fehlings D, et al. Among authors: mesterman r. Can J Neurol Sci. 2012 Jul;39(4):508-15. doi: 10.1017/s0317167100014049. Can J Neurol Sci. 2012. PMID: 22728860

9

The Quality Function Measure: reliability and discriminant validity of a new measure of quality of gross motor movement in ambulatory children with cerebral palsy.

Wright FV, Rosenbaum P, Fehlings D, Mesterman R, Breuer U, Kim M. Wright FV, et al. Among authors: mesterman r. Dev Med Child Neurol. 2014 Aug;56(8):770-8. doi: 10.1111/dmcn.12453. Epub 2014 Apr 7. Dev Med Child Neurol. 2014. PMID: 24702540 Free article. Clinical Trial.

10

Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.

Nguyen L, Mesterman R, Gorter JW. Nguyen L, et al. Among authors: mesterman r. BMC Pediatr. 2018 Jan 4;18(1):1. doi: 10.1186/s12887-017-0974-x. BMC Pediatr. 2018. PMID: 29301539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page